Skip to main content
  • SYNERGY Stent, Durable-Polymer Stents Show Similar Outcomes in TWILIGHT Substudy

    The SYNERGY bioabsorbable-polymer (BP) drug-eluting stent (DES) showed similar clinical outcomes to durable-polymer (DP) DES in high-risk patients undergoing percutaneous coronary intervention (PCI), according to a substudy of the TWILIGHT trial.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details